Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Journal of Surgical Oncology|August 29, 2012
A review of global cancer burden: trends, challenges, strategies, and a role for surgeonsChandrakanth Are, Shireen Rajaram, Madhuri Are, et al.Frontiers in Oncology|December 27, 2021
Prediction Efficacy of Prognostic Nutritional Index and Albumin-Bilirubin Grade in Patients With Intrahepatic Cholangiocarcinoma After Radical Resection: A Multi-Institutional Analysis of 535 PatientsQi Li, Chen Chen, Jian Zhang, et al.Neoplasma|January 22, 2024
Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trialDongming Liu, Han Mu, Changfu Liu, et al.Cancer Science|January 12, 2016
Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30Zhigui Guo, Manqing Cao, Abin You, et al.Cell Death & Disease|May 7, 2020
The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathwayLu Chen, Dongming Liu, Xianfu Yi, et al.Cancers|June 26, 2025
Individualized Prediction of Postoperative Survival in Gallbladder Cancer: A Nomogram Based on SEER Data and External ValidationYayue Liu, Kangwei Zhu, Xindi Tian, et al.Frontiers in Oncology|July 11, 2022
A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional AnalysisQi Li, Jian Zhang, Chen Chen, et al.BMC Cancer|March 29, 2022
Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional studyQi Li, Chen Chen, Jingbo Su, et al.Cell Death & Disease|May 5, 2018
HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathwayLu Chen, Piao Guo, Yuchao He, et al.Journal of Gastrointestinal Oncology|July 15, 2022
Efficacy and safety of sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a two-center study in ChinaShao-Hua Ren, Zi-Lin Cui, Meng-Ran Lang, et al.Pageof 12